Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR18034 for postoperative analgesia in tibial plateau fracture surgery
CTR20212545Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Oct 2021
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal ropivacaine in postoperative pain, sponsored by Hengrui Therapeutics. Started Oct 2021; status: completed.
02
Drugs
liposomal ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20212545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212545.